Skip to content

C50.119

Billable

Malignant neoplasm of central portion of unspecified female breast

HCC Category Mapping

V28HCC 23Melanoma and Other Skin Cancers
0.251
V24HCC 12Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12Breast, Prostate, and Other Cancers and Tumors
0.000
RxHCCHCC 22Cancer, Other Specified Sites
0.000

What This Code Means

Cancer in the central portion of a female breast where the specific side (left or right) is not identified.

Coding Tips

  • This unspecified code should only be used when laterality cannot be determined from documentation
  • Query the provider if possible to determine whether the cancer is in the right or left breast for more specific coding

Clinical Significance

Malignant neoplasm of the central portion of unspecified female breast represents invasive breast cancer requiring staging, treatment planning, and ongoing surveillance. Breast cancer is risk-adjusted because it demands significant healthcare resources including surgery, radiation, chemotherapy, hormonal therapy, and long-term monitoring. The unspecified laterality indicates documentation does not identify the affected side, which should trigger a provider query.

Documentation Requirements

  • Pathologic confirmation of invasive malignancy (biopsy with histologic type — ductal, lobular, etc.)
  • Laterality must be queried if not documented — right or left breast
  • Gender documented as female to support gender-specific code selection
  • Quadrant or subsite location: central portion
  • Tumor size (T stage) and grade
  • Lymph node status (N stage) — axillary, sentinel node biopsy results
  • Estrogen receptor, progesterone receptor, and HER2 status
  • Stage grouping (I-IV)
  • Current treatment status (active treatment, hormonal therapy, surveillance)

Commonly Confused Codes

Code Hierarchy

Open C50.119 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.